Maria Dall'Era, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address10 Koret Way, #241
San Francisco CA 94117
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco2004Fellowship in Rheumatology
    University of California, San FranciscoResidency School of Medicine
    University of California, San FranciscoM.D.1997School of Medicine
    University of California, BerkeleyBA1993Immunology
    Collapse Awards and Honors
    UCSF2007Ira M. Goldstein Award for Outstanding Teaching in Rheumatology
    Lupus Foundation of America2014 Purple Ribbon Award
    UCSF2010Exceptional Physician Award
    UCSF2006Ephraim Engleman Award for Excellence in Arthritis Research
    American College of Rheumatology2018Edmund L. Dubois Memorial Lectureship Award
    Lupus Foundation of America2023Evelyn V. Hess Award

    Collapse Overview 
    Collapse Overview
    Maria Dall’Era is the Jean S. Engleman Distinguished Professor of Medicine and Chief of the Division of Rheumatology at the University of California, San Francisco (UCSF).

    She is Director of the UCSF Rheumatology Clinical Research Center and Lupus Clinic. She also serves as the Chair of the Lupus Clinical Investigators Network (LuCIN) and is a steering committee member of the Lupus Academy, Lupus Forum, and the Lupus 21st Century annual conference. She is the PI of a CDC-funded population- based longitudinal lupus cohort in the San Francisco Bay Area called the California Lupus Epidemiology Study and the PI on clinical trials focused on SLE and lupus nephritis.

    She completed her Medical Degree in 1997, from the University of California, San Francisco, where she later completed her Internship and Residency, and became Chief Resident and the Fellow. She has authored numerous publications in the areas of SLE and lupus nephritis. She is a co-author of the Treatment of Lupus Nephritis chapter in Up-To-Date. She received the Edmund L. Dubois Memorial Lectureship Award from the American College of Rheumatology and the Evelyn V. Hess award from the Lupus Foundation of America.

    Her research interests include systemic lupus erythematosus, lupus nephritis, novel biologic agents, lupus nephritis outcomes, and clinical trials.

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Current challenges in the development of new treatments for lupus. Ann Rheum Dis. 2019 06; 78(6):729-735. Dall'Era M, Bruce IN, Gordon C, Manzi S, McCaffrey J, Lipsky PE. PMID: 30636212.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    2. Mycophenolate mofetil in the treatment of systemic lupus erythematosus. Curr Opin Rheumatol. 2011 Sep; 23(5):454-8. Dall'Era M. PMID: 21720247.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    3. Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies. Curr Rheumatol Rep. 2011 Aug; 13(4):308-16. Dall'era M, Chakravarty EF. PMID: 21584692; PMCID: PMC4400849.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    4. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide. Arthritis Care Res (Hoboken). 2011 Mar; 63(3):351-7. Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D. PMID: 21080348.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    5. Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial. Arthritis Rheum. 2007 Dec; 56(12):4142-50. Dall'Era M, Chakravarty E, Wallace D, Genovese M, Weisman M, Kavanaugh A, Kalunian K, Dhar P, Vincent E, Pena-Rossi C, Wofsy D. PMID: 18050206.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansCellsCTClinical Trials
    Maria's Networks
    Concepts (52)
    Derived automatically from this person's publications.
    Co-Authors (4)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department